Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polfa Kutno is a prominent Polish pharmaceutical manufacturer headquartered in Kutno, Poland, with a history dating back to 1935. The company specializes in the production of generic pharmaceuticals, over-the-counter (OTC) medicines, and dietary supplements, maintaining a particularly strong reputation in the pediatric and vitamin segments. In 2002, Teva Pharmaceutical Industries acquired a majority stake in Polfa Kutno, subsequently integrating it fully into its global operations. Today, the Kutno facility serves as a strategic manufacturing and logistics center for Teva in the Central and Eastern European region. The site is equipped with modern production lines that adhere to international GMP standards, producing a wide range of solid and liquid dosage forms. Polfa Kutno remains a key contributor to the Polish healthcare sector through its extensive portfolio of affordable generic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polfa Kutno.